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Epidemic-Associated Neisseria meningitidis
Detected by Multilocus Enzyme Electrophoresis
In Oregon and parts of Washington State, the
incidence of serogroup B meningococcal disease in-
creased substantially in 1994 (1). Multilocus enzyme
electrophoresis (MEE) subtyping of N. meningitidis
serogroup B strains collected in these areas during
1993 and 1994 suggested that these increases were
due to a group of genetically related strains of the
enzyme type-5 (ET-5) complex. ET-5 N. meningitidis
serogroup B were first recognized in Norway in 1974
as the cause of a meningococcal disease epidemic
that persisted through 1991. Since 1974, serogroup
B meningococci of the ET-5 complex have caused
epidemics in Europe, Cuba, and South America;
these epidemics elevated disease rates for many
years in the affected areas (2,3) and led to sustained
efforts  for  vaccine development. This report de-
scribes the use of MEE to compare invasive N. men-
ingitidis serogroup B meningococcal strains from
Oregon and Washington with epidemic serogroup B
strains from other countries and with serogroup B
strains that have caused endemic disease in other
parts of the United States.
MEE, first described in 1966 as a molecular ap-
proach to the study of genetic variation in eukaryotic
systems, has only gradually been adopted by micro-
biologists and epidemiologists. The fundamental
concept underlying MEE is that differences in the
electrophoretic mobility of constitutive enzymes (re-
sulting from amino acid substitutions) reflect the
chromosomal genotype of strains and thereby allow
the calculation of a genetic-relatedness index (Fig-
ure 1). As recently as 1984, only one bacterial spe-
cies, Escherichia coli, had been studied by MEE.
Since then, however, MEE has been used to charac-
terize genetic variation among populations of Le-
gionella spp.,  Bordetella spp.,  Haemophilus
influenzae, Streptococcus spp., Listeria monocyto-
genes,  Neisseria meningitidis, and other bacteria (4).
To carry out MEE, crude aqueous extracts of
bacteria are electrophoresed in a block of 11% to 12%
starch in the presence of a dilute buffer (pH 8.0). The
block is then cut into thin slices, which are stained
to detect specific enzymes. The distance traveled by
each enzyme is used to create a series of numbers
representing the set of enzyme mobilities charac-
teristic of individual strains. The number of en-
zymes used is somewhat arbitrary and varies
between organisms; 15 to 24 enzymes have usually
been adequate to characterize genetic diversity
among bacterial populations. For this investigation,
electrophoretic variations in 24 enzymes were used
to describe genetic variability among isolates of N.
meningitidis serogroup B. N. meningitidis strains
used for this analysis were collected from Oregon
(1993-1994, n = 64) and part of Washington State
(1993-1994, n  =  17; 1992, n  =  2; 1990, n  =  1; un-
known, n = 2); serogroup B meningococcal epidemics
outside the United States (1976-1993; Norway n =
1; Cuba n = 1; Brazil n = 1; and Chile n = 2); and
active population-based surveillance for meningo-
coccal disease in selected areas of the United States
(1991-1994, from the San Francisco Bay area, Geor-
gia, Maryland, Oklahoma, and Tennessee, n = 57).
The epidemic strains tested from Norway and Cuba
are the type used for the outer membrane protein
vaccines developed and tested in these countries.
The MEE data analyzed here (Figure 1) suggest
that the increased rates of disease in Oregon and
part of Washington are caused by highly genetically
related N. meningitidis serogroup B strains of the
ET-5 complex. These strains have been relatively
rare in the United States. Oregon and Washington
strains match a strain isolated in Santiago, Chile,
during 1993. The prolonged duration of some ET-5
serogroup B meningococcal epidemics in large re-
gions (e.g., Brazil, Argentina, and Chile) demands
careful monitoring of this organism in the United
States. Efforts to identify potentially modifiable risk
factors for the disease and develop a vaccine have
been intensified. MEE will continue to be the pri-
mary means for epidemiologic tracking and surveil-
lance of ET-5 complex N. meningitidis serogroup B
in the United States.
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Figure 1. Genetic relatedness of serogroup B strains of Neisseria meningitidis from Oregon, Washington, other
countries, and endemic-disease cases in the United States.
A. Computer-generated dendrogram for all isolates; 68 enzyme types (ETs) were identified with the 24 enzymes
used in this study. To determine the relatedness of two ETs, start at the left side of the dendrogram at the line (or
leg) representing the ET of interest and follow the leg horizontally to the right angle turn (up or down), allowing a
path to the other ET. The point on the x-axis at which a right angle turn (up or down) is made to move horizontally
back to the left indicates the genetic relatedness. For example, the ET at the top of the dendrogram is related to the other
ETs at slightly more than 0.44; the next two ETs are related to each other at an index of approximately 0.17.
B. Expanded view of dendrogram with a genetic-relatedness index of 0.25 to 0.45. The ET-5 complex cluster is shown
in bold type. This portion of the dendrogram represents the population structure of group B meningococci in this
study; all strains with a genetic-relatedness level of 0.25 or less are shown as single legs or “complexes” of related
strains. The distribution of serogroup B meningococcal strains by site and epidemiologic type (Oregon, Washington,
non-U.S. epidemic, and U.S. endemic) and by ET group (or complex) is shown in columns to the left of the
dendrogram. At a genetic-relatedness level of 0.25, the dendrogram is divided into 11 ET complexes. The ET-5
complex is the ninth leg down (or third from the bottom), shown in bold type. Of strains endemic in the United
States, the highest proportion, 18 (32%) of 56, comprise an ET complex located at the fifth leg from the top and are
related to the ET-5 complex at a genetic-relatedness index of just over 0.35. In contrast, 56 (88%) of 64 Oregon
strains, 16 (73%) of 22 Washington strains, and 5 of 5 non-U.S. epidemic strains are in the ET-5 complex. Only 8
(14%) of 57 strains endemic in the United States are in the ET-5 complex.
C. Expanded view of ET-5 portion of the dendrogram with genetic-relatedness index of 0 to 0.16. The distribution of
strains by site and epidemiologic type, within the ET-5 complex, is shown to the left of the dendrogram; 16 ETs are
represented in the ET-5 complex. The eight strains endemic in the United States in the ET-5 complex are distributed
among seven ETs. Forty-six (82%) of 56 Oregon strains and 14 (88%) of 16 Washington strains are clustered at the
seventh leg down. One of the five non-U.S. epidemic strains, one of the two strains from Chile, and one (of 56) of
strains endemic in the United States match these strains. The other four non-U.S. epidemic strains are located at
the tenth leg down, along with one strain from Oregon; these are related to the cluster at the seventh leg at a
genetic-relatedness index of approximately 0.06. This slight difference in relatedness results from a difference in
the electrophoretic mobility of a single enzyme.
Bacteria strains were provided by  K. Steingart, Southwest Washington Health Dist., and M. Goldoft, Washington Dept.  of Health.
Dispatches
Emerging Infectious Diseases 54 Vol. 1, No. 2 — April-June 1995